P

Inventor

KAUFMANN GUNNAR F

US22 patents
⚠️ This page may combine multiple inventors who share the name “KAUFMANN GUNNAR F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SORRENTO THERAPEUTICS INC

19 patents
US10058609B2Aug 28, 2018

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC17 citations93
US9676853B2Jun 13, 2017

Antigen binding proteins that bind PD-1

SORRENTO THERAPEUTICS INC15 citations92
US10584168B2Mar 10, 2020

Antigen binding proteins that bind PD-1

SORRENTO THERAPEUTICS INC1 citations72
US10472413B2Nov 12, 2019

Anti-infective binding proteins that bind AIP2

SORRENTO THERAPEUTICS INC1 citations72
US10301395B2May 28, 2019

Chemically-locked bispecific antibodies

SORRENTO THERAPEUTICS INC3 citations72
US11878058B2Jan 23, 2024

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC0 citations62
US11318202B2May 3, 2022

Antigen binding proteins that bind WISP1

SORRENTO THERAPEUTICS INC0 citations62
US11242391B2Feb 8, 2022

Antigen binding proteins that bind PD-1

SORRENTO THERAPEUTICS INC0 citations62
US11027012B2Jun 8, 2021

Antigen binding proteins that bind PD-L1

SORRENTO THERAPEUTICS INC0 citations62
US10272154B2Apr 30, 2019

Antigen binding proteins that bind WISP1

SORRENTO THERAPEUTICS INC1 citations62
US11267905B2Mar 8, 2022

Chemically-locked bispecific antibodies

SORRENTO THERAPEUTICS INC0 citations61
US9631009B2Apr 25, 2017

Anti-infective binding proteins that bind AIP2

SORRENTO THERAPEUTICS INC1 citations61
US10435479B2Oct 8, 2019

Chemically-locked bispecific antibodies

SORRENTO THERAPEUTICS INC1 citations60
US10925968B2Feb 23, 2021

Cell internalizing compounds

SORRENTO THERAPEUTICS INC0 citations58
US12180294B2Dec 31, 2024

Dimeric antigen receptors

SORRENTO THERAPEUTICS INC0 citations54
US9879069B2Jan 30, 2018

Antibody therapeutics that bind OprF

SORRENTO THERAPEUTICS INC0 citations52
US10799598B2Oct 13, 2020

Disulfide bridging conjugates

SORRENTO THERAPEUTICS INC0 citations51
US10774135B2Sep 15, 2020

Variant antibodies that bind AIP2

SORRENTO THERAPEUTICS INC0 citations50
US10583193B2Mar 10, 2020

Cell penetrating peptide inhibitors of p53-MDM2 interaction

SORRENTO THERAPEUTICS INC0 citations40

ZHOU HEYUE

1 patent

KAUFMANN GUNNAR F

1 patent

JANDA KIM D

1 patent